(Q34983298)

5 August 2017

1 reference

title

Bladder cancer: epidemiology, diagnosis, and management (English)

1 reference

5 August 2017

1 reference

1 reference

1

Chris Leo Pashos

1 reference

5 August 2017

4

Alberto Redaelli

1 reference

5 August 2017

Marc F Botteman

2

1 reference

5 August 2017

Benjamin Lewis Laskin

series ordinal

3

1 reference

5 August 2017

publication date

1 November 2002

1 reference

5 August 2017

1 reference

5 August 2017

volume

10

1 reference

5 August 2017

issue

6

1 reference

5 August 2017

page(s)

311-322

1 reference

Use of permanent hair dyes and bladder-cancer risk

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5394.2002.106011.X

Schistosomiasis and the risk of bladder cancer in Alexandria, Egypt

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5394.2002.106011.X

Bladder cancer in various population groups in the greater Durban area of KwaZulu-Natal, South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5394.2002.106011.X

Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5394.2002.106011.X

Diet and bladder cancer: a meta-analysis of six dietary variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5394.2002.106011.X

Factors affecting recurrence and progression in superficial bladder tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5394.2002.106011.X

Treatment of superficial bladder tumors: achievements and needs. The EORTC Genitourinary Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5394.2002.106011.X

Recent perspectives in topical therapy in superficial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5394.2002.106011.X

Efficacy and safety of bacille Calmette-Guérin immunotherapy in superficial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5394.2002.106011.X

BCG intravesical instillations: recommendations for side-effects management

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5394.2002.106011.X

Biological response modifiers for the treatment of superficial bladder tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5394.2002.106011.X

Urinary cytokines reflecting the immunological response in the urinary bladder to biological response modifiers: their practical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5394.2002.106011.X

Against bladder sparing: surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5394.2002.106011.X

Bladder cancer: race differences in extent of disease at diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5394.2002.106011.X

Influence of smoking status on the disease-related outcomes of patients with tobacco-associated superficial transitional cell carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5394.2002.106011.X

Preventing progression and improving survival with BCG maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5394.2002.106011.X

Radical cystectomy for invasive bladder cancer: contemporary results and remaining controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5394.2002.106011.X

10.1046/J.1523-5394.2002.106011.X

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference